First U.S. Case with DT MedTech’s H3 Total Ankle

DT MedTech's Hintermann Series H3™ Total Ankle Replacement was successfully implanted in its first U.S. case. Full product launch will commence in late 2019.

The three-component, non-cemented, non-constrained system has been marketed ex-U.S. for 18 years. In 2Q19, the device received FDA Premarket Approval.

H3 complements the company's H2®...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us